Abordagem das Principais Cefaleias Primárias e Nevralgias no Serviço de Urgência: Orientações da Sociedade Portuguesa de Cefaleias
DOI:
https://doi.org/10.46531/sinapse/GU/125/2025Palavras-chave:
Cefaleias/tratamento farmacológico, Enxaqueca/tratamento farmacológico, Serviço de Urgência HospitalarResumo
A cefaleia é um dos sintomas neurológicos mais comuns e uma das queixas mais frequentes em contexto de urgência. Embora seja essencial reconhecer os sinais de alerta associados às dores de cabeça e as possíveis causas secundárias, é também importante gerir adequadamente as cefaleias primárias, com frequência negligenciadas e subtratadas neste setor. Isso aplica-se tanto à população adulta como à pediátrica. Em situações agudas, fármacos como triptanos (para a enxaqueca e a cefaleia em salvas), oxigenoterapia de alto fluxo (para a cefaleia em salvas), medicamentos intravenosos como laçosamida, fenitoína e levetiraectam (para a nevralgia do trigêmeo) e indometacina (para as cefaleias trigémino-autonómicas além da cefaleia em salvas) devem estar disponíveis no serviço de urgência e ser sempre considerados, dependendo das comorbilidades do doente e das possíveis contraindicações. Este documento resume as recomendações dos autores sobre o tratamento das cefaleias primárias e nevralgias mais comuns no serviço de urgência.
Downloads
Referências
Membriilla JA, Alpuente A, Gómez-Dabo L, Raúl GY, Marino E, Díaz-de-Terán J, et al. “Code Headache”: Development of a protocol for optimizing headache management in the emergency room. Eur J Neurol. 2024;31:e16484. doi: 10.1111/ene.16484.
Ardila CM, Gonzalez-Arroyave D, Angel S, Zuluaga-Gomez M. Primary Headache Approach in the Emergency Departments: A Systematic Scoping Review of Prospective Studies. Cureus. 2023. doi:10.7759/Cureus.36131
On behalf of the School of Advanced Studies of the European Headache Federation (EHF-SAS), Deretti A, Shestarite I, Ungaro D, Lee JJ, Lymperopoulos L, et al. Headaches in the emergency department: a survey of patients’ characteristics, facts and needs. J Headache Pain. 2019;20:100. doi:10.1186/s10194-019-1053-5
Wei DY, Khalil M, Goadsby PJ. Managing cluster headache. Pract Neurol. 2019;19:521-8. doi:10.1136/practneurol-2018-002124
Do TF, Remmers A, Schyiz HW, Schankin C, Nelson SE, Obermann M, et al. Red and orange flags for secondary headaches in clinical practice: SNNOCP10 list. Neurology. 2019;92:134-44. doi:10.1212/WNL.0000000000000697
Eigenbrodt AK, Ashina H, Khan S, Diener HC, Mitsikostas DD, Sinclair AJ, et al. Diagnosis and management of migraine in ten steps. Nat Rev Neurol. 2021;17:501-14. doi:10.1038/s41582-021-00509-5
Gil-Gouveia R. Organização de Serviços de Apoio Clínico para Doentes com Cefaleias em Portugal. Sinapse. 2021;21:112-20. doi:10.46531/sinapse/GU/200034/2021
Sacco S, Braschinsky M, Ducros A, et al. European headache federation consensus on the definition of resistant and refractory migraine : Developed with the endorsement of the European Migraine & Headache Alliance (EMHA). J Headache Pain. 2020;21(1):76. doi:10.1186/s10194-020-01130-5
Alfani J. Acute Migraine Treatment. CONTINUUM: Lifelong Learning in Neurology. 2021;22(3):597-612. doi:10.1212/ CON.0000000000000956
Viana M, Genazzani AA, Terrazzino S, Nappi G, Goadsby PJ. Triptan nonresponders: Do they exist and who are they? Cephalalgia. 2013;33:891-6. doi:10.1177/0333102413480756
Edvinsson L, Hannes KA, Warfvinge K, Krause DN. CGRP as the target of new migraine therapies - successful translation from bench to clinic. Nat Rev Neurol. 2018;14:338-50. doi:10.1038/s41582-018-0003-1
Jiménez M. La Sociedad Española de Neurología (SEN) publica el “Manual de Urgencias Neurológicas”, patrocinado en exclusiva por Adamed. Adamed Laboratorios. May 16, 2023. [Accessed February 25, 2024]. Available at: https://www.adamedfarma.es/la-sociedad-espanola-de-neurologia-sen-publica-el-manual-de-urgencias-neurologi-cas-patronadio-en-exclusiva-por-adamed/
Worthington J, Pringsheim T, Gawel MJ. Pharmacological Acute Migraine Treatment Strategies: Choosing the Right Drug for a Specific Patient. Can J Neurol Sci. 2013;40:S33-S62. doi:10.1017/S0317167100118979
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629-808. doi:10.1177/0333102413485658
Bahra A, Amer MA, Thomas P, Fuccaro M, Lambru G. Trigeminal autonomic cephalalgias. In: Zakrzewska JM, Nurmikko T, editors. Trigeminal Neuralgia and Other Cranial Neuralgias. Oxford: Oxford University Press; 2021. p.161-86. doi:10.1093/med/9780198871606.003.0014
Parreira E. Recomendações Terapêuticas para Cefaleias da Sociedade Portuguesa de Cefaleias – 2021. Sinapse. 2021;21(supplement 1):3-100. doi:10.46531/sinapse/GU/200048/2021
Eller M, Goodsby P. Trigeminal autonomic cephalalgias. Oral Diseases. 2016;22:1-8. doi:10.1111/odi.12263
Cittadini E, Matharu MS, Goodsby PJ. Paroxysmal hemicrania: a prospective clinical study of 31 cases. Brain. 2008;131:1142-55. doi:10.1093/brain/awn010
May A, Schulte LH. Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol. 2016;12:455-64. doi:10.1038/nrneurol.2016.93
Cohen AS, Burns B, Goodsby PJ. High-Flow Oxygen for Treatment of Cluster Headache: A Randomized Trial. JAMA. 2009;302:2451. doi:10.1001/jama.2009.1855
Leone M, Bussone G. Pathophysiology of trigeminal autonomic cephalalgias. The Lancet Neurology. 2009;8:755-64. doi:10.1016/S1474-4422(09)70133-4
Schnell S, Marrodan M, Acosta JN, Bonamico L, Goicochea MT. Trigeminal Neuralgia Crisis – Intravenous Phenytoin as Acute Rescue Treatment. Headache. 2020;60:2247-2253. doi:10.1111/head.13963
Bendtsen L, Zakrzewska JM, Abbott J, Braschinsky M, Di Stefano G, Donnet A, et al. European Academy of Neurology guideline on trigeminal neuralgia. Eur J Neurol. 2019;26:831-49. doi:10.1111/ene.13950
Muñoz-Vendrell A, Teixidor S, Sala-Padró J, Campoy S, Huerta-Villanueva M. Intravenous lacosamide and phenytoin for the treatment of acute exacerbations of trigeminal neuralgia: A retrospective analysis of 144 cases. Cephalalgia. 2022;42:1031-8. doi:10.1177/03331024221092435
Baydoun J, Lin A, Miya J. Low-dose Fosphenytoin for Aborting Acute Trigeminal Neuralgia Pain: A Case Report. Clin Pract Cases Emerg Med. 2023;7. doi:10.5811/CPCEM.1603
Moore D, Chong MS, Shetty A, Zakrzewska JM. A systematic review of rescue analgesic strategies in acute exacerbations of primary trigeminal neuralgia. British Journal of Anaesthesia. 2019;123:e385-e396. doi:10.1016/j.bja.2019.05.026
Lambru G, Zakrzewska J, Matharu M. Trigeminal neuralgia: a practical guide. Pract Neurol. 2021;21:392-402. doi:10.1136/practneurol-2020-002782
Jorns TP, Johnston A, Zakrzewska JM. Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia. Euro J of Neurology. 2009;16:740-44. doi:10.1111/j.1468-1331.2009.02585.x
Mitsikostas DD, Pantes GV, Avramidis TG, Karageorgiou KE, Gatzonis SD, Stathis PG, et al. An observational trial to investigate the efficacy and tolerability of levetiracetam in trigeminal neuralgia. headache. 2010;50:1371-7. doi:10.1111/j.1526-4610.2010.01743.x
Stavropoulou E, Argyra E, Zis P, Vadalouca A, Siafaka I. The Effect of Intravenous Lidocaine on Trigeminal Neuralgia: A Randomized Double Blind Placebo Controlled Trial. ISRN Pain. 2014;2014:1-5. doi:10.1155/2014/853826
Zhou X, Shen Y, Zhao C, Luo F. Lidocaine aerosol sprayed on oral and/or nasal mucosa for the rescue of acute trigeminal neuralgia exacerbations: A retrospective study. Cephalalgia. 2023;43(5):033310242311680. doi:10.1177/03331024231168086
Han KR, Kim C, Chae YJ, Kim DW. Efficacy and safety of high concentration lidocaine for trigeminal nerve block in patients with trigeminal neuralgia: Trigeminal nerve block with high concentration lidocaine. Int J Clin Pract. 2007;62:248-54. doi:10.1111/j.1742-1241.2007.01568.x
Kanai A, Saito M, Hoka S. Subcutaneous Sumatriptan for Refractory Trigeminal Neuralgia. Headache. 2006;46:577-82. doi:10.1111/j.1526-4610.2006.00405.x
Zúñiga C, Piedimonte F, Díaz S, Micheli F. Acute Treatment of Trigeminal Neuralgia With Onabotulinum Toxin A. Clin Neuropharmacol. 2013;36:146-50. doi:10.1097/WNF.0b013e31829cb66b
Raucol U, Della Vecchia N, Ossella C, Ossella C, Paolino MC, Villa MP, et al. Management of Childhood Headache in the Emergency Department. Review of the Literature. Front Neurol. 2019;10:886. doi:10.3389/fneur.2019.00886
Souza-e-Silva HR, Rocha-Filho PA. Headaches and Academic Performance in University Students: A Cross-Sectional Study: November/December 2011. Headache: The Journal of Head and Face Pain. 2011;51:1493-502. doi:10.1111/j.1526-4610.2011.02012.x
Abu-Artefeh I, Russell G. Prevalence of headache and migraine in Adoloclinidae. BMJ. 1994;309:765-9. doi:10.1136/bmj.309.6957.765
Lopes Freitas E. Estudo da abrasqueca em idade pediátrica nos cuidados de saúde primários da região Centro de Portugal. Sinapse. 2020;20:9-16. doi:10.46531/sinapse/2020/AO/200007/2020
Kacperski J, Kabbuche MA, O’Brien HL, Weberding JL. The optimal management of headaches in children and adolescents. Ther Adv Neurol Disord. 2016;9:53-68. doi:10.1177/1756285615616586
Richer L, Billinghurst L, Lindell MA, Russell K, Vandermeer B, Crumley ET, et al. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev. 2016;4:C0005220. doi:10.1002/14651858.CD005220.pub2.
Brousseau DC, Duffy SJ, Anderson AC, Linaids JG. Treatment of pediatric migraine headaches. Ann Emerg Med. 2004;43:256-62. doi:10.1016/S0196-0644(03)00716-9
Pugliese A, Beltramo T, Torre D. Reye’s and Reye’s-like syndromes. Cell Biochemistry & Function. 2008;26:741-6. doi:10.1002/cbf.1465
Barbarini P, Grazzi L, Egeo G. Pharmacotherapy for acute migraines in children and adolescents. Exp Opin Pharmacother. 2019;20:455-63. doi:10.1080/14656566.2018.1552941
Winner P, Linder S, Hershey AD. Consistency of Response to Sumatriptan/Naproxen Sodium in a Randomized Placebo Controlled, Cross Over Study for the Acute Treatment of Migraine in Adolescence. Headache. 2015;55:519-28. doi:10.1111/head.12555
Talai A, Heilbrunn B. Ondansetron for Acute Migraine in the Pediatric Emergency Department. Pediat Neurol. 2020;103:52-6. doi:10.1016/j.pediatneurol.2019.06.011
Sheridan DC, Laurie A, Pacheco S, Fu R, Hansen ML, Ma OL, et al. Relative Effectiveness of Dopamine Antagonists for Pediatric Migraine in the Emergency Department. Pediatr Emer Care. 2018;34:165-8. doi:10.1097/PEC.0000000000000718
Chua AL, Grossberg BM, Evans RW. Status Migrainosus in Children and Adults. Headache. 2019;59:1611-23. doi:10.1111/head.13676
Sheridan D, Sun B, O’Brien P, Hansen M. Intravenous sodium valproate for acute pediatric headache. J Emerg Med. 2015;49:541-5. doi:10.1016/j.jemermed.2015.02.024
Reiter PD, Nickisch J, Merritt G. Efficacy and tolerability of intravenous valproic acid in acute adolescent migraine. Headache. 2005;45:899-903. doi:10.1111/j.1526-4610.2005.05158.x
Kanis JM, Timm NL. Chlorpromazine for the treatment of migraine in a pediatric Emergency Department. Headache. 2014;54:335-42. doi:10.1111/head.12255
Löligen RM, Babil FE, Mackay MT, Hill A, Palmer GM. Intravenous chlorpromazine for acute paediatric migraine. Emerg Medicine Australasia. 2022;34(4):623-625. doi:10.1111/1742-6723.13985
Orr SL, Friedman BW, Christie S, Minen MT, Barnford C, Kelley NE, et al. Management of Adults with Acute Migraine in the Emergency Department: The American Headache Society Evidence Assessment of Parenteral Pharmacotherapies. Headache. 2016;56:911-40. doi:10.1111/head.12835
Cobb-Pitstick KM, Hershey AD, O’Brien HL, Kabbouche MA, LeCates S, White S, et al. Factors Influencing Migraine Recurrence After Infusion and Inpatient Migraine Treatment in Children and Adolescents. Headache. 2015;55:1397-403. doi:10.1111/head.12654
Bastos SN, Barbosa BL, Silva SF, Krymchantowski AG, Jevoux C, Krymchantowski A, et al. Cluster headache in children and adolescents: a systematic review of case reports. Develop Med Child Neuro. 2021;63:1155-60. doi:10.1111/dmcn.14923
Bramell A, Kachko L, Eidlitz-Markus T. Trigeminal neuralgia in children and adolescents: experience of a tertiary pediatric headache clinic. Headache. 2021;61:137-42. doi:10.1111/head.14023
Downloads
Publicado
Como Citar
Edição
Secção
Licença
Direitos de Autor (c) 2026 Filipe Palavra, Paula Salgado, Renato Oliveira, Sara Machado
Este trabalho encontra-se publicado com a Creative Commons Atribuição-NãoComercial 4.0.
